Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Longitudinal, Prospective, French, Multicentre Study Conducted on Adult and Paediatric Patients Treated With Micafungin in Prophylaxis and Followed Over a 3 Months' Period in Routine Medical Practice

NCT02127788 is registered in ClinicalTrials.gov with Astellas Pharma S.A.S. as lead sponsor.

NCT NCT02127788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Longitudinal, Prospective, French, Multicentre Study Conducted on Adult and Paediatric Patients Treated With Micafungin in Prophylaxis and Followed Over a 3 Months' Period in Routine Medical Practice
Lead sponsor
Astellas Pharma S.A.S.
Phase
Observational
Overall status
Completed
Start date
July 3, 2014
Completion date
January 27, 2016
Enrollment
150 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

antifungal prophylaxis, haemopathy